Oriental Biotech announced that its wholly-owned subsidiary US Hengjian Biotechnology Co., Ltd. (“American Hengjian”) (collectively, the “Company”) recently obtained the US Food and Drug Administration FDA 510 (K) license for fentanyl urine test reagents (professional/self-test) and EU IVDR for drug testing analyzers.
东方生物：芬太尼尿液检测试剂取得医疗器械注册证
Oriental Biology: Fentanyl urine test reagent obtains medical device registration certificate
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.